The safety profile of telmisartan in patients treated for the reduction of cardiovascular morbidity was consistent with that obtained in hypertensive patients.
De bloeddruk kan te laag worden als u telmisartan samen met andere bloeddrukverlagers gaat gebruiken.
Therefore, monitor digoxin levels when initiating, adjusting, and discontinuing telmisartan for the purpose of keeping the digoxin level within the therapeutic range.
Laboratory and or medical tests such as kidney function, potassium levels should be performed periodically to monitor your progress or check for side effects.
No telmisartan-treated patients discontinued therapy because of abnormal hepatic function. Store at room temperature away from light and moisture. When pregnancy is detected, discontinue MICARDIS as soon as possible. There was no evidence of carcinogenicity when telmisartan was administered in the diet to mice and rats for up to 2 years.
From the Bioengineering and Chronobiology Laboratories R.
Ask your doctor before use if you are taking the following medications:
Evidence quality was poor and results should be interpreted cautiously.
This may increase the risk that you will get a serious infection.
Your doctor may ask you to stop smoking or at least cut down.
You may not experience any of them. The study was terminated early because of an increased risk of adverse outcomes. Do not use this medicine if you are pregnant. Otherwise, your doctor may think that it was not effective and change your treatment unnecessarily.